Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON35619Withdrawn
Open-label, single-arm trial of rocuronium and Sugammadex, sponsored by Radboud University Medical Center. Primary endpoints: Classification rate of the EEG algorithm and Event-related desynchronization and synchronization features. Planned start Jan 2012; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON35619.